Evaluation of VTE-PREDICT Risk Score in Patients Receiving Low-Dose DOACs for Venous Thromboembolism (VTE) Secondary Prophylaxis.
Mediterr J Hematol Infect Dis
; 16(1): e2024047, 2024.
Article
in En
| MEDLINE
| ID: mdl-38882449
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mediterr J Hematol Infect Dis
Year:
2024
Document type:
Article